LISATA THERAPEUTICS, INC. Amortization of Intangible Assets
LISATA THERAPEUTICS, INC. (LSTA) reported Amortization of Intangible Assets of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-06
- LISATA THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $12.00K, a 33.33% decline year-over-year.
- LISATA THERAPEUTICS, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $18.00K, a 0.00% change year-over-year.
- LISATA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2025 was $65.00K, a 8.45% decline from fiscal 2024.
- LISATA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2024 was $71.00K, a 0.00% change from fiscal 2023.
- LISATA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2023 was $71.00K, a 238.10% increase from fiscal 2022.
- LISATA THERAPEUTICS, INC. amortization of intangible assets for fiscal 2022 was $21.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $12.00K derived: sum of 3 quarters · filed 2026-08-06 | $30.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $12.00K derived: sum of 2 quarters · filed 2026-05-11 | $30.00K derived: sum of 3 quarters · filed 2026-05-11 | $48.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $30.00K derived: sum of 2 quarters · filed 2026-03-12 | $48.00K derived: sum of 3 quarters · filed 2026-08-06 | $65.00K 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $18.00K 10-Q · filed 2025-11-06 | $36.00K derived: sum of 2 quarters · filed 2026-08-06 | $53.00K 10-Q · filed 2025-11-06 | $71.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $18.00K 10-Q · filed 2026-08-06 | $35.00K 10-Q · filed 2026-08-06 | $53.00K derived: sum of 3 quarters · filed 2026-08-06 | $71.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $17.00K 10-Q · filed 2026-05-11 | $35.00K derived: sum of 2 quarters · filed 2026-05-11 | $53.00K derived: sum of 3 quarters · filed 2026-05-11 | $71.00K derived: sum of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $36.00K derived: sum of 2 quarters · filed 2026-03-12 | $54.00K derived: sum of 3 quarters · filed 2026-03-12 | $71.00K 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $18.00K 10-Q · filed 2025-11-06 | $36.00K derived: sum of 2 quarters · filed 2025-11-06 | $53.00K 10-Q · filed 2025-11-06 | $71.00K derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $18.00K 10-Q · filed 2025-08-07 | $35.00K 10-Q · filed 2025-08-07 | $53.00K derived: sum of 3 quarters · filed 2025-08-07 | $71.00K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $17.00K 10-Q · filed 2025-05-08 | $35.00K derived: sum of 2 quarters · filed 2025-05-08 | $53.00K derived: sum of 3 quarters · filed 2025-05-08 | $71.00K derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $36.00K derived: sum of 2 quarters · filed 2025-02-27 | $54.00K derived: sum of 3 quarters · filed 2025-02-27 | $71.00K 10-K · filed 2025-02-27 | $21.00K 10-K · filed 2024-02-29 | ||
| 2023-09-30 | $18.00K 10-Q · filed 2024-11-12 | $36.00K derived: sum of 2 quarters · filed 2024-11-12 | $53.00K 10-Q · filed 2024-11-12 | $72.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $18.00K 10-Q · filed 2024-08-12 | $35.00K 10-Q · filed 2024-08-12 | $54.00K derived: sum of 3 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $18.00K 10-Q · filed 2024-05-09 | $36.00K derived: sum of 2 quarters · filed 2024-05-09 | |||||
| 2022-12-31 | $18.00K 10-K · filed 2023-03-30 | $21.00K 10-K · filed 2023-03-30 | |||||
| 2017-03-31 | $142.50K 10-Q · filed 2017-05-15 | ||||||
| 2016-12-31 | $570.00K 10-K · filed 2017-03-17 | ||||||
| 2016-06-30 | $142.50K 10-Q · filed 2016-11-07 | $427.50K 10-Q · filed 2016-11-07 | $285.00K 10-Q · filed 2016-08-09 | $436.30K derived: sum of 3 quarters · filed 2017-05-15 | $587.60K derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2016-03-31 | $142.50K 10-Q · filed 2017-05-15 | $293.80K derived: sum of 2 quarters · filed 2017-05-15 | $445.10K derived: sum of 3 quarters · filed 2017-05-15 | $596.40K derived: sum of 4 quarters · filed 2017-05-15 | |||
| 2015-12-31 | $151.30K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $302.60K derived: sum of 2 quarters · filed 2017-03-17 | $453.90K derived: sum of 3 quarters · filed 2017-03-17 | $605.20K 10-K · filed 2017-03-17 | |||
| 2015-09-30 | $151.30K 10-Q · filed 2015-11-05 | $302.60K derived: sum of 2 quarters · filed 2016-11-07 | $453.90K 10-Q · filed 2015-11-05 | $756.50K derived: sum of 4 quarters · filed 2016-11-07 | |||
| 2015-06-30 | $151.30K 10-Q · filed 2016-11-07 | $453.90K 10-Q · filed 2016-11-07 | $302.60K 10-Q · filed 2015-08-06 | $605.20K derived: sum of 3 quarters · filed 2016-11-07 | $756.50K derived: sum of 4 quarters · filed 2016-11-07 | ||
| 2015-03-31 | $151.30K 10-Q · filed 2016-05-05 | $453.90K derived: sum of 2 quarters · filed 2016-05-05 | $605.20K derived: sum of 3 quarters · filed 2016-05-05 | $756.50K derived: sum of 4 quarters · filed 2016-05-05 | |||
| 2014-12-31 | $302.60K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $453.90K derived: sum of 2 quarters · filed 2016-03-15 | $605.20K derived: sum of 3 quarters · filed 2016-03-15 | $605.20K 10-K · filed 2016-03-15 | |||
| 2014-09-30 | $151.30K 10-Q · filed 2015-11-05 | $302.60K derived: sum of 2 quarters · filed 2015-11-05 | $302.60K 10-Q · filed 2015-11-05 | $453.90K 10-Q · filed 2014-10-30 | $605.20K derived: sum of 4 quarters · filed 2016-03-15 | ||
| 2014-06-30 | $151.30K 10-Q · filed 2015-08-06 | $302.60K 10-Q · filed 2015-08-06 | $453.90K derived: sum of 3 quarters · filed 2016-03-15 | $605.20K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | $151.30K 10-Q · filed 2015-05-06 | $302.60K derived: sum of 2 quarters · filed 2016-03-15 | $453.90K derived: sum of 3 quarters · filed 2016-03-15 | $605.20K derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2013-12-31 | $151.30K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $302.60K derived: sum of 2 quarters · filed 2016-03-15 | $453.90K derived: sum of 3 quarters · filed 2016-03-15 | $605.20K 10-K · filed 2016-03-15 | |||
| 2013-09-30 | $151.30K 10-Q · filed 2013-11-07 | $302.60K derived: sum of 2 quarters · filed 2013-11-07 | $453.90K 10-Q · filed 2014-10-30 | $605.20K derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-06-30 | $151.30K 10-Q · filed 2013-08-08 | $302.60K 10-Q · filed 2014-08-07 | $453.90K derived: sum of 3 quarters · filed 2015-03-02 | $605.20K derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-03-31 | $151.30K 10-Q · filed 2014-05-08 | $302.60K derived: sum of 2 quarters · filed 2015-03-02 | $453.90K derived: sum of 3 quarters · filed 2015-03-02 | $605.20K derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | $151.30K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $302.60K derived: sum of 2 quarters · filed 2015-03-02 | $453.90K derived: sum of 3 quarters · filed 2015-03-02 | $605.20K 10-K · filed 2015-03-02 | |||
| 2012-09-30 | $151.30K 10-Q · filed 2013-11-07 | $302.60K derived: sum of 2 quarters · filed 2013-11-07 | $453.90K 10-Q · filed 2013-11-07 | $440.00K derived: sum of 4 quarters · filed 2013-11-07 | |||
| 2012-06-30 | $151.30K 10-Q · filed 2013-08-08 | $302.60K 10-Q · filed 2013-08-08 | $288.70K derived: sum of 3 quarters · filed 2013-08-08 | $500.00K derived: sum of 4 quarters · filed 2013-08-08 | |||
| 2012-03-31 | $151.30K 10-Q · filed 2013-05-09 | $137.40K derived: sum of 2 quarters · filed 2013-05-09 | $348.70K derived: sum of 3 quarters · filed 2013-05-09 | $357.50K derived: sum of 4 quarters · filed 2013-05-09 | |||
| 2011-12-31 | -$13.90K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $197.40K derived: sum of 2 quarters · filed 2013-03-11 | $206.20K derived: sum of 3 quarters · filed 2013-03-11 | $577.30K 10-K · filed 2013-03-11 | |||
| 2011-09-30 | $211.30K 10-Q · filed 2012-11-13 | $220.10K derived: sum of 2 quarters · filed 2012-11-13 | $591.20K 10-Q · filed 2012-11-13 | ||||
| 2011-06-30 | $8.80K 10-Q · filed 2012-08-14 | $17.60K 10-Q · filed 2012-08-14 | |||||
| 2010-12-31 | $35.20K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |